| BD | barbital-dependent; barbiturate dependence; base deficit; base of prism down; basophilic degeneratio... |
|---|---|
| Xan | xanthine |
| XDH | xanthine dehydrogenase |
| XDP | xanthine diphosphate; xeroderma pigmentosum |
| XMP | xanthine monophosphate |
| X-XO | Xanthine-xanthine oxidase |
|---|---|
| BD | bronchodilator |
| MIX | 1-Methyl-3-isobutyl-xanthine |
| 1-MX | 1-methyl xanthine |
| 1X | 1-methyl xanthine |
| xanthine bronchodilator | <pharmacology> A group of medications that work by a common mechanism to effect bronchodilation (open up air passages) in the lungs. Used in the treatment of asthma and related conditions. Examples include: theophylline, aminophylline and dyphylline. (27 Sep 1997) |
|---|
| adrenergic bronchodilator | <pharmacology> A medication that acts to dilate (enlarge) the lumen of the airway to allow the unrestricted passage of air. These medications are commonly given to those with asthma who manifest wheezing. Examples include: theophylline, aminophylline, adrenaline, Alupent, metaproterenol, isoproterenol, Ventolin, Proventil, bitolterol, salmeterol, pirbuterol and albuterol. See: wheezing. (27 Sep 1997) |
|---|---|
| bronchodilator | <pharmacology> A medication that acts to dilate (enlarge) the lumen of the airway to allow the unrestricted passage of air. These medications are commonly given to those with asthma who manifest wheezing. Examples include: theophylline, aminophylline, adrenaline, Alupent, metaproterenol, isoproterenol, Ventolin, Proventil, bitolterol, salmeterol, pirbuterol and albuterol. See: wheezing. (27 Sep 1997) |
| bronchodilator agents | Drugs that cause expansion of the lumina of the air passages of the lungs. (12 Dec 1998) |
| methyl xanthine | <chemical, drug> Naturally occurring purine alkaloids such as theobromine, theophylline and caffeine (trimethyl xanthine). They inhibit cAMP phosphodiesterase and thus cause an increase in the intracellular cAMP concentration. (18 Nov 1997) |
| xanthine | <biochemistry> A purine, the starting point for purine degradation. Its methylated derivatives (theophylline, theobromine, caffeine) are potent cAMP phosphodiesterase inhibitors. (18 Nov 1997) |
| xanthine alkaloids | Alkaloids, which contain xanthine as their nitrogenous base. (12 Dec 1998) |
| xanthine dehydrogenase | <enzyme> An enzyme that catalyses the oxidation of xanthine in the presence of NAD+ to form urate and NADH. It acts also on a variety of other purines and aldehydes. Chemical name: Xanthine:NAD+ oxidoreductase Registry number: EC 1.1.1.204 (12 Dec 1998) |
| xanthine nucleotide | The monophosphoric ester of xanthosine. An intermediate in GMP biosynthesis. Synonym: xanthidylic acid, xanthine nucleotide, xanthylic acid. (05 Mar 2000) |
| xanthine oxidase | <enzyme> Dehydrogenases involved in conversion of hypoxanthine to xanthine and xanthine to uric acid, as the final catabolism of purines. Deficient in the human disease xanthinuria. (18 Nov 1997) |
| xanthine ribonucleoside | 9-beta-d-ribosylxanthine;the deamination product of guanosine (O replacing -NH2). Synonym: xanthine ribonucleoside. Abbreviation: Xao (05 Mar 2000) |
| hypoxanthine-guanine-xanthine phosphoribosyltransferase | <enzyme> From tritrichomonas foetus; in contrast to EC 2.4.2.8, this enzyme also uses xanthine as substrate; mw 24 kD Registry number: EC 2.4.2.- Synonym: hgxprtase (26 Jun 1999) |
| desulfo xanthine dehydrogenase | <enzyme> Naturally occuring inactive form of xanthine dehydrogenase Registry number: EC 1.1.1.- (26 Jun 1999) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|